Nimesulide painkiller restricted in India: Why oral doses above 100 mg are banned
The Indian government has banned the manufacture and sale of oral nimesulide formulations above 100 mg. Know why the popular painkiller was restricted, the health risks involved, and what it means for patients. New Delhi: In response to safety concerns regarding the risk of Nimesulide, the Union Health Ministry of India has banned the manufacturing, selling, and distributing of Nimesulide oral formulations that contain higher than 100 milligrams (mg) of Nimesulide per dose for human consumption as a precaution. This ban is now effective and was initiated as a means to safeguard public health. Why the Government Took Action Nimesulide is a type of non-steroidal anti-inflammatory drug (NSAID) commonly used for pain relief and fever reduction. While it has been widely prescribed in India, experts and regulators have long worried about its potential to cause serious side effects, especially with higher doses. According to the Health Ministry’s notification, high-dose oral forms ...